KDIGO AKI staging: creatinine versus urine output
This patient’s acute kidney injury is staged by applying the KDIGO criteria to two separate signals: the rise in serum creatinine and the fall in urine output. The two criteria do not always point to the same stage, and the rule is to assign the
higher stage when there is a discrepancy.
His creatinine rose from 1.0 to 2.1 mg/dL, which is 2.1 times his baseline. In the KDIGO framework, a creatinine increase of
2.0–2.9 times baseline defines
stage 2. A rise of 1.5–1.9 times would be stage 1, and a rise of 3.0 times or more, or an absolute increase to 4.0 mg/dL or higher, or initiation of renal replacement therapy, would be stage 3.
The urine output data require a weight-based calculation. Over the last 8 hours, his total urine output was
130 mL. For a 70 kg patient, that is 130 ÷ 8 ÷ 70, approximately
0.23 mL/kg/h. Urine output below
0.5 mL/kg/h for 6 hours or more meets the threshold for
stage 1 by urine output. The stage 3 urine output criterion is stricter: less than
0.3 mL/kg/h for
24 hours or more, or anuria for 12 hours or more. Because this patient’s oliguria has been documented for only 8 hours, the urine output criterion does not yet support stage 3.
| KDIGO criterion | Stage 1 | Stage 2 | Stage 3 |
|---|
| Serum creatinine | 1.5–1.9 × baseline or increase ≥0.3 mg/dL | 2.0–2.9 × baseline | ≥3.0 × baseline, or creatinine ≥4.0 mg/dL, or RRT |
| Urine output | <0.5 mL/kg/h for 6–12 h | <0.5 mL/kg/h for ≥12 h | <0.3 mL/kg/h for ≥24 h, or anuria ≥12 h |
Key point! The final KDIGO stage is the
higher of the creatinine-based stage and the urine output-based stage. Here, creatinine places the patient at stage 2, while urine output places him at stage 1. The assigned stage is therefore
stage 2.
Watch out! Do not automatically call this stage 3 just because the hourly urine output is very low. The stage 3 oliguria threshold of less than 0.3 mL/kg/h requires a sustained duration of
24 hours, and this patient has only 8 hours of documentation at the time of assessment.
The clinical context reinforces why accurate staging matters. This patient has upper gastrointestinal bleeding in the setting of dual antiplatelet therapy after coronary stenting. The combination of hypotension, tachycardia, and a falling urine output points to
prerenal hypoperfusion as a major contributor to the AKI. KDIGO emphasizes that once AKI is identified, the cause should be sought and the severity staged, because more severe AKI carries a greater risk of progression to chronic kidney disease. In this patient, the creatinine-based stage 2 classification identifies a clinically significant injury that warrants close monitoring of volume status, hemodynamics, and renal recovery.